References
- Dal Prato L, Borini A, Trevisi M R, Bonu M A, Sereni E, Flamigni C. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Hum Reprod 2001; 16: 1409–1414
- Gindes L, Yoeli R, Orvieto R, Shelef M, Ben-Rafael Z, Bar-Hava I. Pregnancy rate fluctuations during routine work of assisted reproduction technology unit. Hum Reprod 2003; 18: 2485–2488
- Bar-Hava I, Ashkenazi J, Shelef M, Schwartz A, Brengauz M, Feldberg D, Orvieto R, Ben-Rafael Z. Morphology and clinical outcomes of embryos after in vitro fertilization are superior to those after intracytoplasmic sperm injection. Fertil Steril 1997; 68: 653–657
- Beloosesky R, Kol S, Lightman A, Itskovitz-Eldor J. Ovarian stimulation in in vitro fertilization with or without the ‘long’ gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome. Fertil Steril 2000; 74: 166–168
- Halme J, Hammond M G, Talbert L M, O'Rand M, Bailey L, Sloan C. Positive correlation between body weight, length of human menopausal gonadotropin stimulation, and oocyte fertilization rate. Fertil Steril 1986; 45: 372–376
- Ragni G, De Laurentis L, Perotti L, Serra A D, Vegetti W, Crosignani P G. Effects of different amounts of LH on superovulation induction with long-acting GnRH in an IVF program. Int J Fertil Menopausal Stud 1996; 41: 466–469
- Tanos V, Friedler S, Shushan A, Strauss N, Hetsroni I, Lewin A. Comparison between nafarelin acetate and D-Trp6-LHRH for temporary pituitary suppression in in vitro fertilization (IVF) patients: a prospective crossover study. J Assist Reprod Genet 1995; 12: 715–719